Financial results - QUADRANT ONCOLOGY S.R.L.

Financial Summary - Quadrant Oncology S.r.l.
Unique identification code: 40686448
Registration number: J16/821/2019
Nace: 8622
Sales - Ron
33.407
Net Profit - Ron
13.614
Employee
The most important financial indicators for the company Quadrant Oncology S.r.l. - Unique Identification Number 40686448: sales in 2023 was 33.407 euro, registering a net profit of 13.614 euro and having an average number of employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Quadrant Oncology S.r.l.

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR - - - - - 3.422 5.386 13.082 21.617 33.407
Total Income - EUR - - - - - 3.422 5.386 13.082 21.617 33.407
Total Expenses - EUR - - - - - 1.385 2.934 2.807 4.516 16.834
Gross Profit/Loss - EUR - - - - - 2.037 2.452 10.275 17.101 16.574
Net Profit/Loss - EUR - - - - - 1.935 2.299 9.883 16.453 13.614
Employees - - - - - 0 0 0 0 0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 55.0%, from 21.617 euro in the year 2022, to 33.407 euro in 2023. The Net Profit decreased by -2.789 euro, from 16.453 euro in 2022, to 13.614 in the last year.

Check the financial reports for the company - Quadrant Oncology S.r.l.

Rating financiar

Financial Rating -
Quadrant Oncology S.r.l.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Quadrant Oncology S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Quadrant Oncology S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Quadrant Oncology S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Quadrant Oncology S.r.l. - CUI 40686448

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets - - - - - 7.884 5.614 3.416 2.523 838
Current Assets - - - - - 1.876 2.228 8.608 22.162 14.120
Inventories - - - - - 0 0 0 0 0
Receivables - - - - - 0 0 0 375 0
Cash - - - - - 1.876 2.228 8.608 21.787 14.120
Shareholders Funds - - - - - 1.977 4.238 9.931 16.501 13.662
Social Capital - - - - - 42 41 40 41 40
Debts - - - - - 7.784 3.604 2.093 8.183 1.296
Income in Advance - - - - - 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 14.120 euro in 2023 which includes Inventories of 0 euro, Receivables of 0 euro and cash availability of 14.120 euro.
The company's Equity was valued at 13.662 euro, while total Liabilities amounted to 1.296 euro. Equity decreased by -2.789 euro, from 16.501 euro in 2022, to 13.662 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Quadrant Oncology S.r.l.

Comments - Quadrant Oncology S.r.l.

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.